ARCHIVES

FDA Didn’t Tell Advisors About Data Linking Obesity Drug With Precancerous Lesions.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

Afinitor Tablet Doubles PFS; Lowers Progression Risk 65%

February 25, 2011

In Brief: Potter Resigns As director Of Lombardi Cancer Center; Search Committee To Look for Successor

July 24, 1987

For Research Projects In Cancer Therapy

March 1, 1996

Healy’s “Save Bob” Campaign

January 6, 1995

UHC Expands Risk Models To Include 25 Cancer Variables

February 24, 2012

Congress Investigates “Lecture Awards” To Former NCI Director Richard Klausner.

July 4, 2003